Login
Nature Biotechnology 26, 151 - 154 (2008) doi:10.1038/nbt0208-151
Nuala Moran1
Is NICE's approach to cost-effectiveness turning the UK into a biotech-free zone? Nuala Moran investigates.
ADVERTISEMENT
Top